论文部分内容阅读
目的探讨颅内血肿微创清除术治疗重症高血压性脑出血临床疗效。方法将60例重症高血压性脑出血患者随机分为两组,对照组(n=30)给予常规综合治疗,治疗组(n=30)在对照组相同治疗的基础上给予颅内血肿微创清除术,比较两组的死亡率和患者半年后日常生活能力(ADL)。结果治疗组死亡率为6.7%(2/30)明显低于对照组33.3%(10/30)(P<0.01)。生存者半年后的ADLⅠ-Ⅲ级,治疗组67.9%(19/28)明显优于对照组45.0%(9/20)(P<0.01)。结论颅内血肿微创清除术治疗重症高血压性脑出血具有临床效果好、创伤小、死亡率低、术后恢复好等优点,值得临床推广应用。
Objective To investigate the clinical effect of minimally invasive intracranial hematoma removal in the treatment of severe hypertensive intracerebral hemorrhage. Methods Sixty patients with severe hypertensive intracerebral hemorrhage were randomly divided into two groups. The control group (n = 30) was given conventional comprehensive treatment. The treatment group (n = 30) was given minimally invasive intracranial hematoma based on the same treatment as the control group Surgery was performed to compare the two groups of death rates and patients’ daily living ability (ADL) after six months. Results The mortality in the treatment group was 6.7% (2/30), which was significantly lower than that in the control group (33.3%, 10/30) (P <0.01). Survival after six months of ADL Ⅰ-Ⅲ grade, the treatment group 67.9% (19/28) was significantly better than the control group 45.0% (9/20) (P <0.01). Conclusion Intracranial hematoma minimally invasive surgical treatment of severe hypertensive intracerebral hemorrhage has the advantages of good clinical effect, small trauma, low mortality and good postoperative recovery, which is worthy of clinical application.